Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Drug company (FDA labeler)

Sigmapharm Laboratories, LLC

NDC labeler code: 42794

What is a labeler?

The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.

Official FDA data only

Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.

Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.

At a glance

27Products (NDC)

Prescription medicines

FDA applications for these products

  • ANDA: Abbreviated New Drug Application: how a generic version is approved.
ApprovedApplicationMedicineSponsor
December 10, 2020ANDA206107 Asenapine
ASENAPINE MALEATE
Sigmapharm Labs LLC
April 10, 2019ANDA208354 Ambrisentan
AMBRISENTAN
Sigmapharm Labs LLC
March 26, 2018ANDA207746 Dofetilide
DOFETILIDE
Sigmapharm Labs LLC
May 22, 2015ANDA204633 Acitretin
ACITRETIN
Sigmapharm Labs LLC
August 29, 2013ANDA202051 Adefovir dipivoxil
ADEFOVIR DIPIVOXIL
Sigmapharm Labs LLC
November 29, 2012ANDA200295 Liothyronine sodium
LIOTHYRONINE SODIUM
Sigmapharm Labs LLC
October 22, 2012ANDA202482 Griseofulvin
GRISEOFULVIN
Sigmapharm Labs LLC
October 22, 2012ANDA202545 Griseofulvin
GRISEOFULVIN,ULTRAMICROSIZE
Sigmapharm Labs LLC
June 28, 2011ANDA201566 Flucytosine
FLUCYTOSINE
Sigmapharm Labs LLC
March 28, 2011ANDA091619 Disulfiram
DISULFIRAM
Sigmapharm Labs LLC
May 3, 2010ANDA090462 Protriptyline hydrochloride
PROTRIPTYLINE HYDROCHLORIDE
Sigmapharm Labs LLC
January 30, 2009ANDA079133 Amiloride
AMILORIDE HYDROCHLORIDE
Sigmapharm Labs LLC

The sponsor is the company that holds the FDA application; it can differ from the labeler.

Recall timeline

2021

  1. April 19, 2021 · Class III · Terminated · D-0379-2021 · Asenapine

    Incorrect Product Formulation; product was manufactured with the incorrect Art Cherry Flavor flavoring agent instead of Art Black Cherry Flavor flavoring agent

    Asenapine Sublingual Tablets, 5 mg, Rx Only, 60 Tablets, Sigmapharm Laboratories, LLC, Bensalem, PA, 19020 NDC 42794-016-10.

  2. April 19, 2021 · Class III · Terminated · D-0380-2021 · Asenapine

    Incorrect Product Formulation; product was manufactured with the incorrect Art Cherry Flavor flavoring agent instead of Art Black Cherry Flavor flavoring agent

    Asenapine Sublingual Tablets, 10 mg, Rx only, 60 Tablets, Sigmapharm Laboratories, LLC, Bensalem, PA, 19020, NDC 42794-017-10

2014

  1. April 22, 2014 · Class II · Terminated · D-1344-2014 · Liothyronine sodium

    Cross Contamination with Other Products: Four lots of Liothyronine Sodium Tablets, USP 5 mcg are being recalled due to the finding of a potential carryover of trace amounts of a previously manufactured product.

    Liothyronine Sodium Tablets, USP 5 mcg, Rx Only, a) 100-count bottle NDC 42794-018-02 and b) 1000-count bottle NDC 42794-018-06, SigmaPharm Laboratories, LLC, Bensalem, Pa.

What do the recall classes mean?

Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026

FDA Enforcement Report search → · Report an error →